Key facts
- This page summarizes Thomas Bush III's Form 4 filing for BIO KEY INTERNATIONAL INC (BKYI).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 15 May 2023, 16:31.
Thomas Bush III - 11 May 2023 Form 4 Insider Report for BIO KEY INTERNATIONAL INC (BKYI)
- Reporting relationship
- Director
- Issuer ticker
- BKYI
- Reported as of
- 11 May 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 May 2023, 16:31:58 UTC
- Prior SEC filing
- 20 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas Bush III
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Thomas Bush III filed Form 4 for BIO KEY INTERNATIONAL INC (BKYI) on 15 May 2023.
Change
- Previous filing in this sequence was filed on 20 Mar 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BKYI
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +4,348
- Change %
- +21%
- Price
- $0.000000
- Shares after
- 24,793
- Date
- 11 May 2023
- Ownership
- Direct
- Footnotes
- F1
BKYI
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +1,450
- Change %
- +5.8%
- Price
- $0.000000
- Shares after
- 26,243
- Date
- 11 May 2023
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents shares issued to the Reporting Person on May 11, 2023 under the Issuer's Amended and Restated 2015 Equity Incentive Plan in payment of board meeting attendance fees.
Footnote F2
Represents shares issued to the Reporting Person on May 11, 2023 under the Issuer's Amended and Restated 2015 Equity Incentive Plan in payment of board committee meeting attendance fees.